Company

Sotio Biotech A.S.

Sotio Biotech develops immunotherapies for cancer.

About

Founded in 2010 by Radek Spisek and based in Prague, Czech Republic, Sotio Biotech develops cancer immunotherapies. Its pipeline includes SOT101, SOT201, SOT103, SOT102, SOT107, BOXR1030 and SOT302; SOT101 was in a phase 1/1b trial. In December 2021, PPF Group invested EUR 280 million to support clinical development.

2Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in